
Oxford Nanopore Technologies:
Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis.
The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments.
With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
The Role:
Oxford Nanopore Technologies is seeking a commercially driven and scientifically credible Clinical Sales Specialist to accelerate the adoption of nanopore sequencing within clinical and translational healthcare environments across Southern Europe, covering Italy & Benelux. In this field-based role, this individual will actively develop the clinical market need for Oxford Nanopore's unique and highly differentiated sequencing portfolio.
Please note that the successful candidate must be based in either Italy or the Netherlands for this position.
Reporting to the Director, Clinical Sales Specialist, you will form part of a global team of experienced sales and market development professionals acting to deliver commercial targets and to actively drive awareness of Oxford Nanopore Technologies' products across EMEAI. The successful candidate will be responsible for driving growth of our clinical business by identifying customer-led opportunities and working to develop new clinical applications.
This role combines strategic account management, business development, and clinical market expertise to drive growth across existing and emerging clinical applications. The successful candidate will build trusted relationships with key clinical stakeholders, identify new opportunities, and position ONT solutions within evolving healthcare and diagnostic workflows.
The role is ideal for an experienced genomics or diagnostics commercial professional who thrives in fast-moving environments and enjoys combining scientific depth with commercial impact.
Responsibilities:
Clinical Sales and Business Growth
Customer and Stakeholder Management
Product and Market Alignment
Sales Excellence
Channel Parter Collaboration
Requirements:
This role will suit someone keen to join a disruptive, cutting-edge high-tech organisation and who is confident working under pressure with minimum supervision in a matrix sales and service environment. You will have a desire to lead and inspire both internally and externally.
Your passion for changing healthcare and outcomes for patients will be your ‘why’.
If you are looking to utilise your skills to really make a difference to humankind, then consider joining our team and apply today!
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-JR1
#LI-hybrid
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.